ADT Inc. ( NYSE:ADT ), might not be a large cap stock, but it had a relatively subdued couple of weeks in terms ...
Discover ADT’s Q3 2025 earnings highlights: strong revenue growth, AI-driven efficiency, and confident outlook.
Artificial intelligence: where do we begin? Do we start with the data, or do we start by reinventing our processes?
Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 agonists for diabetes, with new data for Mounjaro on cardiovascular outcomes. The results of the SURPASS-CVOT trial showed ...
The brain’s function and integrity emerge not only from properties of individual regions, but, more fundamentally, from the intricate web of connections ...